Hepatic myelopathy as a presenting neurological complication in patients with cirrhosis and spontaneous splenorenal shunt.
10.3350/kjhep.2008.14.1.89
- Author:
Ja Eun KOO
1
;
Young Suk LIM
;
Sun Jeong MYUNG
;
Kyung Suk SUH
;
Kang Mo KIM
;
Han Chu LEE
;
Young Hwa CHUNG
;
Yung Sang LEE
;
Dong Jin SUH
Author Information
1. Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. limys@amc.seoul.kr
- Publication Type:Case Report
- Keywords:
Hepatic myelopathy;
Liver cirrhosis;
Splenorenal shunt
- MeSH:
Adult;
Disease Progression;
Evoked Potentials, Motor/physiology;
Hepatitis B, Chronic/complications/diagnosis;
Hepatitis C, Chronic/complications/diagnosis;
Humans;
Liver Cirrhosis/*complications/diagnosis;
Liver Transplantation;
Magnetic Resonance Imaging;
Male;
Middle Aged;
Paraparesis, Spastic/etiology/pathology;
Renal Veins/*radiography;
Spinal Cord Diseases/*diagnosis/etiology/radiography;
Splenic Vein/*radiography;
Tomography, X-Ray Computed;
Vascular Fistula/*radiography
- From:The Korean Journal of Hepatology
2008;14(1):89-96
- CountryRepublic of Korea
- Language:English
-
Abstract:
Hepatic myelopathy is a rare complication of chronic liver disease that is associated with extensive portosystemic shunts. The main clinical feature of hepatic myelopathy is progressive spastic paraparesis in the absence of sensory or sphincter impairment. Early and accurate diagnosis of hepatic myelopathy is important because patients with early stages of the disease can fully recover following liver transplantation. Motor-evoked potential studies may be suitable for the early diagnosis of hepatic myelopathy, even in patients with preclinical stages of the disease. Here we describe two patients who presented with spastic paraparesis associated with a spontaneous splenorenal shunt and without any previous episode of hepatic encephalopathy. One patient experienced improved neurologic symptoms after liver transplantation, whereas the other patient only received medical treatment, which did not prevent the progression of spastic paraparesis.
